ArthroCare Corporation Announces Reflex Ultra(R) PTR Plasma Wand Designed For Precise Turbinate Reduction In Pediatric Patients

AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare® Corp. (NASDAQ:ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced today the launch of the ReFlex Ultra® PTR Plasma Wand. The wand is designed for use in volumetric turbinate reduction procedures to treat nasal airway obstructive disorders – such as turbinate hypertrophy in allergic rhinitis for pediatric patients.

MORE ON THIS TOPIC